Annual Total Long Term Liabilities
$6200.00
-$55.20 K-89.90%
30 September 2023
Summary:
Outlook Therapeutics annual total long term liabilities is currently $6200.00, with the most recent change of -$55.20 thousand (-89.90%) on 30 September 2023. During the last 3 years, it has fallen by -$11.45 million (-99.95%). OTLK annual total long term liabilities is now -99.98% below its all-time high of $27.22 million, reached on 30 September 2014.OTLK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$88.21 M
-$50.97 M-36.62%
30 June 2024
Summary:
Outlook Therapeutics quarterly total long term liabilities is currently $88.21 million, with the most recent change of -$50.97 million (-36.62%) on 30 June 2024. Over the past year, it has increased by +$88.21 million (+1422664.52%). OTLK quarterly long term liabilities is now -36.62% below its all-time high of $139.18 million, reached on 31 March 2024.OTLK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +10000.0% |
| 3 y3 years | -100.0% | +670.3% |
| 5 y5 years | -99.9% | +1058.4% |
OTLK Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | at low | -36.6% | >+9999.0% |
| 5 y | 5 years | -100.0% | at low | -36.6% | >+9999.0% |
| alltime | all time | -100.0% | at low | -36.6% | >+9999.0% |
Outlook Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $88.21 M(-36.6%) |
| Mar 2024 | - | $139.18 M(>+9900.0%) |
| Dec 2023 | - | $59.60 K(+861.3%) |
| Sept 2023 | $6200.00(-89.9%) | $6200.00(-69.0%) |
| June 2023 | - | $20.00 K(+141.0%) |
| Mar 2023 | - | $8300.00(-100.0%) |
| Dec 2022 | - | $31.85 M(>+9900.0%) |
| Sept 2022 | $61.40 K(-99.5%) | $61.40 K(-18.9%) |
| June 2022 | - | $75.70 K(-75.8%) |
| Mar 2022 | - | $312.30 K(-96.8%) |
| Dec 2021 | - | $9.91 M(-13.5%) |
| Sept 2021 | $11.45 M(+1025.5%) | $11.45 M(+2217.2%) |
| June 2021 | - | $494.20 K(-12.2%) |
| Mar 2021 | - | $562.80 K(-94.8%) |
| Dec 2020 | - | $10.87 M(+968.3%) |
| Sept 2020 | $1.02 M | $1.02 M(+23.5%) |
| June 2020 | - | $823.60 K(-91.8%) |
| Mar 2020 | - | $9.99 M(-36.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | - | $15.73 M(+106.6%) |
| Sept 2019 | $7.61 M(-31.1%) | $7.61 M(-32.9%) |
| June 2019 | - | $11.35 M(-14.2%) |
| Mar 2019 | - | $13.23 M(+4.6%) |
| Dec 2018 | - | $12.64 M(+14.4%) |
| Sept 2018 | $11.05 M(-51.4%) | $11.05 M(-0.3%) |
| June 2018 | - | $11.09 M(-1.9%) |
| Mar 2018 | - | $11.30 M(+26.0%) |
| Dec 2017 | - | $8.97 M(-60.5%) |
| Sept 2017 | $22.72 M(+124.0%) | $22.72 M(+234.1%) |
| June 2017 | - | $6.80 M(-28.7%) |
| Mar 2017 | - | $9.54 M(-6.0%) |
| Dec 2016 | - | $10.15 M(+0.1%) |
| Sept 2016 | $10.14 M(-62.7%) | $10.14 M(+19.4%) |
| June 2016 | - | $8.49 M(-8.9%) |
| Mar 2016 | - | $9.32 M(-7.3%) |
| Dec 2015 | - | $10.06 M(-63.1%) |
| Sept 2015 | $27.22 M(0.0%) | $27.22 M |
| Sept 2014 | $27.22 M | - |
FAQ
- What is Outlook Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly long term liabilities year-on-year change?
What is Outlook Therapeutics annual total long term liabilities?
The current annual total long term liabilities of OTLK is $6200.00
What is the all time high annual total long term liabilities for Outlook Therapeutics?
Outlook Therapeutics all-time high annual total long term liabilities is $27.22 M
What is Outlook Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of OTLK is $88.21 M
What is the all time high quarterly long term liabilities for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly total long term liabilities is $139.18 M
What is Outlook Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, OTLK quarterly total long term liabilities has changed by +$88.21 M (+1422664.52%)